User:Olivier Laprevote/Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 46: Line 46:
== Vav activity ==
== Vav activity ==
-
Upon antigen recognition in BCR and TCR pathways, '''Src family kinases''' phosphorylate Y174 residue of Vav1, so that activated Vav1 can then express its GEF activity on Rac1 [18]. The PH domain structures the protein so that DH and C1 are available for Rac1 binding. The C1 domain is rich in cysteine and harbours two Zn fingers involved in the binding of RhoGTPases <ref> PMID:2620086 </ref>.
+
Upon antigen recognition in BCR and TCR pathways, '''Src family kinases''' phosphorylate Y174 residue of Vav1, so that activated Vav1 can then express its GEF activity on Rac1 <ref> http://www.ebi.ac.uk/intact/interaction/EBI-7944187;jsessionid=8AD6943D454A170511925DF549C751E4 </ref>. The PH domain structures the protein so that DH and C1 are available for Rac1 binding. The C1 domain is rich in cysteine and harbours two Zn fingers involved in the binding of RhoGTPases <ref> PMID:2620086 </ref>.
Rac1 has two '''switch regions''' that bind to C1 and DH domain. The first switch binds to two highly conserved regions of C1 domain, CR1 (Conserved Region)and CR3. The second switch binds to CR3 and to the C-terminal α-helix of DH domain. These two domains widen the binding cavity to mediate the release of GDP to exchange for GTP <ref> PMID:2620086 </ref>.
Rac1 has two '''switch regions''' that bind to C1 and DH domain. The first switch binds to two highly conserved regions of C1 domain, CR1 (Conserved Region)and CR3. The second switch binds to CR3 and to the C-terminal α-helix of DH domain. These two domains widen the binding cavity to mediate the release of GDP to exchange for GTP <ref> PMID:2620086 </ref>.

Revision as of 22:57, 27 January 2017

Proto-oncogene vav

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. http://mcb.asm.org/content/20/5/1461.full
  2. http://www.proteinatlas.org/ENSG00000141968-VAV1/tissue
  3. Fujikawa K, Miletic AV, Alt FW, Faccio R, Brown T, Hoog J, Fredericks J, Nishi S, Mildiner S, Moores SL, Brugge J, Rosen FS, Swat W. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med. 2003 Nov 17;198(10):1595-608. PMID:14623913 doi:http://dx.doi.org/10.1084/jem.20030874
  4. Quaranta MG, Mattioli B, Spadaro F, Straface E, Giordani L, Ramoni C, Malorni W, Viora M. HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells. FASEB J. 2003 Nov;17(14):2025-36. PMID:14597672 doi:http://dx.doi.org/10.1096/fj.03-0272com
  5. http://smart.embl.de/smart/show_motifs.pl?GENOMIC=1&DO_PFAM=DO_PFAM&INCLUDE_SIGNALP=INCLUDE_SIGNALP&ID=9606.ENSP00000472929
  6. Yu B, Martins IR, Li P, Amarasinghe GK, Umetani J, Fernandez-Zapico ME, Billadeau DD, Machius M, Tomchick DR, Rosen MK. Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1. Cell. 2010 Jan 22;140(2):246-56. PMID:20141838 doi:10.1016/j.cell.2009.12.033
  7. Llorca O, Arias-Palomo E, Zugaza JL, Bustelo XR. Global conformational rearrangements during the activation of the GDP/GTP exchange factor Vav3. EMBO J. 2005 Apr 6;24(7):1330-40. Epub 2005 Mar 10. PMID:15775967 doi:http://dx.doi.org/10.1038/sj.emboj.7600617
  8. Yu B, Martins IR, Li P, Amarasinghe GK, Umetani J, Fernandez-Zapico ME, Billadeau DD, Machius M, Tomchick DR, Rosen MK. Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1. Cell. 2010 Jan 22;140(2):246-56. PMID:20141838 doi:10.1016/j.cell.2009.12.033
  9. http://pfam.xfam.org/family/PF00621
  10. Movilla N, Bustelo XR. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol Cell Biol. 1999 Nov;19(11):7870-85. PMID:10523675
  11. Han J, Luby-Phelps K, Das B, Shu X, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA, Broek D. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science. 1998 Jan 23;279(5350):558-60. PMID:9438848
  12. Chu DH, Morita CT, Weiss A. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol Rev. 1998 Oct;165:167-80. PMID:9850860
  13. Kon-Kozlowski M, Pani G, Pawson T, Siminovitch KA. The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells. J Biol Chem. 1996 Feb 16;271(7):3856-62. PMID:8632004
  14. Bustelo XR, Crespo P, Lopez-Barahona M, Gutkind JS, Barbacid M. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation. Oncogene. 1997 Nov 20;15(21):2511-20. PMID:9399639
  15. PMID: 24736456 
  16. PMID: 20141838
  17. Barreira M, Fabbiano S, Couceiro JR, Torreira E, Martinez-Torrecuadrada JL, Montoya G, Llorca O, Bustelo XR. The C-terminal SH3 domain contributes to the intramolecular inhibition of Vav family proteins. Sci Signal. 2014 Apr 15;7(321):ra35. doi: 10.1126/scisignal.2004993. PMID:24736456 doi:http://dx.doi.org/10.1126/scisignal.2004993
  18. PMID: 20141838
  19. http://www.ebi.ac.uk/intact/interaction/EBI-7944187;jsessionid=8AD6943D454A170511925DF549C751E4
  20. Koutsouris D, Guillet R, Wenby RB, Meiselman HJ. Determination of erythrocyte transit times through micropores. II. Influence of experimental and physicochemical factors. Biorheology. 1989;26(5):881-98. PMID:2620086
  21. Koutsouris D, Guillet R, Wenby RB, Meiselman HJ. Determination of erythrocyte transit times through micropores. II. Influence of experimental and physicochemical factors. Biorheology. 1989;26(5):881-98. PMID:2620086

Proteopedia Page Contributors and Editors (what is this?)

Olivier Laprevote

Personal tools